RSS
CEVEC Pharmaceuticals
Exclusive licensing agreement announced for production of recombinant proteins
Producer of tailor-made recombinant glycoproteins and gene therapy vectors, CEVEC Pharmaceuticals, and global biotechnology company, CSL, have announced an exclusive licensing agreement to produce a recombinant C1 Esterase Inhibitor. more
Patent granted to CAP-Go technology for recombinant glycoproteins
CEVEC Pharmaceuticals has been granted a patent for its expression technology CAP-Go, strengthening the company’s position in producing recombinant proteins with tailor-made glycosylation. more
